| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/09/2008 | CN100360129C Dehydro eleagnine derivative, its synthesizing method and use |
| 01/09/2008 | CN100360128C Huperzine-A oral cavity disintegration tablet and its preparation method |
| 01/09/2008 | CN100360127C Ornidazole effervescent tablet |
| 01/09/2008 | CN100360126C Method for treating ischemic stroke with melatonin |
| 01/09/2008 | CN100360125C Compounding composite contg. glutamine and its use |
| 01/09/2008 | CN100360124C Use of 2-amino-2(2-(4-octyl phenyl)ethyl)-1,3-propylene glycol in the preparation of medicaments of preventing and curing immune liver injury |
| 01/09/2008 | CN100360123C Methods and pharmaceutical compostions employing desmethylselegiline |
| 01/09/2008 | CN100360122C Preventive and/or therapeutic agent for viral infection |
| 01/09/2008 | CN100360121C Methods and compositions for preventing and treating chronological aging in human skin |
| 01/09/2008 | CN100360117C Pharmaceutical compositions with improved dissolution |
| 01/09/2008 | CN100360116C Powder formulations suitable for inhalation |
| 01/09/2008 | CN100360115C Molecular coating method of plant polyphenol kind substance |
| 01/09/2008 | CN100360044C Method for preparing stomach-benefiting, digestion-promoting soybean milk sheet comprising micron pine pollen, fig, chickens gizzard-membrane etc. |
| 01/08/2008 | USRE40000 Method of treatment for decreasing mortality resulting from congestive heart failure |
| 01/08/2008 | US7317127 Heating the tomoxetine racemate, a lower alcohol, an aromatic solvent, and (S)-(+)-mandelic acid; crystallizing (R)-(-)-tomoxetine (S)-(+)-mandelate |
| 01/08/2008 | US7317125 Diacylglycerol acyltransferase inhibitors |
| 01/08/2008 | US7317115 Mandelates salts of substituted tetracyclic tetrahydrofuran derivatives |
| 01/08/2008 | US7317114 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-Chagas chemoprophylactic and therapeutical activities |
| 01/08/2008 | US7317109 (2R)-1-{2-[(3S)-Pyrrolidin-3-ylamino]-acetyl}-pyrrolidine-2-boronic acid; antidiabetic |
| 01/08/2008 | US7317108 Acylating 1-monoacyldipyrromethane with an acid halide acylating agent in the presence of a Grignard reagent, to produce 1,9-diacyldipyrromethane metal complex;chemical intermediates; porphyrins |
| 01/08/2008 | US7317107 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity |
| 01/08/2008 | US7317101 Antibacterial cephalosporins |
| 01/08/2008 | US7317087 Members of the FC receptor homolog gene family (FCRH1-3, 6), related reagents, and uses thereof |
| 01/08/2008 | US7317040 Nitric oxide synthase inhibitor phosphate salt |
| 01/08/2008 | US7317039 Deuterated substituted dihydrofuranones and medicaments containing these compounds |
| 01/08/2008 | US7317038 1,3-Diacetyl-8-hydroxy-2-(7-hydroxychromanon-3-yl)-9H-xanthen-9-ones; obtained from a culture of the Penicillium strain SPF-3059; prevents growth cone collapse |
| 01/08/2008 | US7317037 5-(2-Cyano-5-pyrolyl)-2-indolinones: 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'yl)-1-methyl-1H-pyrrole-2-carbonitrile; contraceptives, hormone replacement therapy, dysmenorrhea, premenstrual syndrome, hormone-dependent neoplasia, uterine bleeding |
| 01/08/2008 | US7317036 Prostaglandins for prostaglandin mediated diseases such as antihistamines |
| 01/08/2008 | US7317035 Tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/08/2008 | US7317034 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 01/08/2008 | US7317033 Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 01/08/2008 | US7317032 Imidazolyl inhibitors of 15-lipoxygenase |
| 01/08/2008 | US7317031 3-(SO2-substituted anilino)-5-amino-1-((hetero)aryl-carbonyl- or sulfonyl)-1H-1,2,4-triazoles: 4-[[5-amino-1-[(3-methyl-2-thienyl)carbonyl]-1H-1,2,4-triazol-3-yl]amino]-benzenesulfonamide; for treating melanoma; cervical, ovarian and prostate adenocarcinoma; colon carcinoma and breast cancer |
| 01/08/2008 | US7317030 Compounds as inhibitors of cell proliferation and viral infections |
| 01/08/2008 | US7317029 3-(3-Amino-4-chloro-phenyl)-5-(3-chlorothiophen-2-yl)-[1,2,4]-oxadiazole; anticancer agents; coadministering with other chemotherapeutics or radiotherapy |
| 01/08/2008 | US7317028 Antitumor agents; autoimmune disease; skin disorders; anticancer agents |
| 01/08/2008 | US7317027 Azaindole-derivatives as factor Xa inhibitors |
| 01/08/2008 | US7317026 Sleep disorders; side effect reduction ; antihistamine antagonist |
| 01/08/2008 | US7317025 Non-peptidic NPY Y2 receptor inhibitors |
| 01/08/2008 | US7317024 Obesity, diabetes, inflammatory and immune diseases |
| 01/08/2008 | US7317023 Diaryl ether β2 adrenergic receptor agonists |
| 01/08/2008 | US7317022 3-isopropyl-2-oxo-2,3-dihydrobenzoimidazole-1-carboxylic acid [(1S,3R,5R)-8-((S)-2-hydroxy-3-methylamino-propyl)-8-azabicyclo[3.2.1]oct-3-yl]-amide; bioavailability upon oral administration; medical conditions mediated by 5-HT4 receptor activity |
| 01/08/2008 | US7317021 Cancers that express nitric oxide synthase; 2-[2-(2-Amino-4-methylpyridin-6-yl)ethyl]-3H-imidazo[4,5-b]pyridine |
| 01/08/2008 | US7317020 Isolation and structure of Cribrostatin 6 |
| 01/08/2008 | US7317019 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 01/08/2008 | US7317018 The use of adenosine-5'-triphosphate-2',3'-dialdehyde (oATP) as a medicament useful for the treatment of inflammatory conditions |
| 01/08/2008 | US7317017 A2B adenosine receptor antagonists |
| 01/08/2008 | US7317016 Methods of treating medical conditions using sulfonate-substituted pyrazolopyridine derivatives |
| 01/08/2008 | US7317014 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 01/08/2008 | US7317013 such as N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-{4-[1-(2-hydroxyethyl)piperidin-4-yl]butyl} guanidine dihydrochloride and optionally with g-coupled receptor agonist or bronchodilators, used for promoting hydration of mucosal surfaces; improved pharmacokinetics |
| 01/08/2008 | US7317012 Bicyclic heterocycles as cannabinoind-1 receptor modulators |
| 01/08/2008 | US7317011 Method of treating peripheral neuropathy |
| 01/08/2008 | US7317010 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
| 01/08/2008 | US7317009 Pyrrolopyridazine derivatives |
| 01/08/2008 | US7317008 Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
| 01/08/2008 | US7317007 Such as 4-(4-Methoxy-7-morpholin-4-yl-benzothiazol-2-ylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester; for prevention of illnesses based on the modulation of the adenosine system, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain |
| 01/08/2008 | US7317006 Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity |
| 01/08/2008 | US7317005 Cyclic oligopeptide; hypotensive agents; congestive heart failure, antiischemic agents, cirrhosis, kidney failure, strokes; thrombosis |
| 01/08/2008 | US7317004 fusing cells: nucleic acid vector comprises a nucleotide sequence encoding a syncytium-inducing polypeptide that is expressible on a eukaryotic cell surface and comprises a sequence of a gibbon ape leukemia virus |
| 01/08/2008 | US7317001 Inhibiting relapse of antibiotic-associated diarrhea in a patient by administering ramoplanin in an amount and for a duration effective to inhibit relapse of antibiotic associated diarrhea in the patient |
| 01/08/2008 | US7316900 Comprises methylated antisense oligonucleotide sequence for regulation of urokinase type plasminogen activator and treatment of cancer |
| 01/08/2008 | US7316821 A controlled release layered bead coated with an aqueuous ethyl cellulose dispersion; time-release agents; improved storage stability |
| 01/08/2008 | US7316820 Applying an ethoxylated oil (Kayuuputih Eucalyptus oil, macadamia nut oil or meadow foam oil) containing 10-19 ethoxy units/molecule to reducie the appearance a varicose or spider vein or a stretch mark; nonsteroidal antiinflammatory drugs, collagen, skin brighteners (tyrosinase inhibitor) |
| 01/08/2008 | US7316818 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
| 01/08/2008 | US7316815 Polyamino acid derivatives and use thereof in compositions for treating keratin fibers |
| 01/08/2008 | US7316811 Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles |
| 01/08/2008 | US7316810 Foaming composition for washing and treating hair and/or scalp based on an active principle |
| 01/08/2008 | CA2503006C Cyclooxygenase-2 inhibitory withanolide compositions and method |
| 01/08/2008 | CA2439291C Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists |
| 01/08/2008 | CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 01/08/2008 | CA2410237C Adenosine a2a receptor antagonists |
| 01/08/2008 | CA2408602C Phenylglycine derivatives |
| 01/08/2008 | CA2402668C Use of cdp-choline for the prophylactic treatment of cerebral ischemia |
| 01/08/2008 | CA2394027C New derivatives of octahydro-2h-pyrido[1,2-a] pyrazine, their preparation process and pharmaceutical compositions that contain them |
| 01/08/2008 | CA2389170C A process for the production of epinastine hydrochloride in the high-melting crystal modification |
| 01/08/2008 | CA2347750C Pharmaceutical composition containing decursin |
| 01/08/2008 | CA2346350C Intraoral quickly disintegrating tablets |
| 01/08/2008 | CA2338600C Novel thiazolopyrimidine compounds |
| 01/08/2008 | CA2337885C Enteric coated pharmaceutical tablet and method of manufacturing |
| 01/08/2008 | CA2334298C Neuropeptide y5 receptor antagonists |
| 01/08/2008 | CA2322028C Spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin and a method of making such spray-dried tablettable powders |
| 01/08/2008 | CA2306824C Encapsulation method |
| 01/08/2008 | CA2296031C Novel spiroazabicyclic heterocyclic compounds |
| 01/08/2008 | CA2284314C A process for producing solid dosage forms |
| 01/08/2008 | CA2277877C Nitric oxide synthase inhibitors |
| 01/08/2008 | CA2272720C New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them |
| 01/08/2008 | CA2267630C Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 01/08/2008 | CA2267315C Ethylamine derivatives |
| 01/08/2008 | CA2236078C Prophylactic or therapeutic agents for diseases associated with dysfunction of nos |
| 01/08/2008 | CA2235375C Production of analgesic synergy by co-administration of sub-analgesic doses of a .mu. opioid agonist and a .kappa.-2 opioid agonist |
| 01/08/2008 | CA2232310C Stable compositions containing n-propargyl-1-aminoindan |
| 01/08/2008 | CA2228060C Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics |
| 01/08/2008 | CA2203901C Polymeric wound healing accelerators |
| 01/08/2008 | CA2196690C Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function |
| 01/08/2008 | CA2192433C Anti-herpesvirus compounds and methods for identyfying, making and using same |
| 01/08/2008 | CA2181164C Anti-gram-positive bacterial methods and materials |
| 01/08/2008 | CA2175603C Estrogen compositions and methods for neuroprotection |
| 01/08/2008 | CA2172513C Aminocyclohexylesters and uses thereof |
| 01/08/2008 | CA2156194C New a83543 compounds and process for production thereof |
| 01/08/2008 | CA2121716C Method and medical agent for diagnosis of arthritis |